Gonvers J J, Loup P, Brunner H R, Mosimann R, Hofstetter J R
Schweiz Med Wochenschr. 1981 Feb 14;111(7):220-3.
Amongst the surgical treatments that have been suggested for refractory ascites, the one that has met with the greatest success is the LeVeen shunt. It nevertheless involves certain risks and might even be fatal. The authors' brief experience in this domain has confirmed its positive immediate effects and has also brought to light some of its drawbacks. The large number of potential complications leads one to conclude that the LeVeen shunt should be reserved for refractory ascites and hepato-renal syndrome, and should not be prematurely employed in other situations.
在针对顽固性腹水所提出的外科治疗方法中,取得最大成功的是LeVeen分流术。然而,它存在一定风险,甚至可能致命。作者在这一领域的简短经验证实了其积极的即时效果,也揭示了一些缺点。大量潜在并发症使人得出结论,LeVeen分流术应仅用于顽固性腹水和肝肾综合征,不应在其他情况下过早使用。